Cargando…

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma

We undertook a study of tumour infiltrating lymphocytes (TILs) in a large and relatively homogeneous group of patients with completely resected esophageal squamous cell carcinoma (ESCC). Hematoxylin and eosin–stained sections of 235 ESCC tumours were evaluated for density of TILs in intratumoural (i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Dongxian, Liu, Yalan, Wang, Hao, Wang, Haixing, Song, Qi, Sujie, Akesu, Huang, Jie, Xu, Yifan, Zeng, Haiying, Tan, Lijie, Hou, Yingyong, Xu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359661/ https://www.ncbi.nlm.nih.gov/pubmed/28322245 http://dx.doi.org/10.1038/srep44823

Ejemplares similares

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2016)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Chromosomal and Genomic Variations in Esophageal Squamous Cell Carcinoma: A Review of Technologies, Applications, and Prospections
por: Song, Qi, et al.
Publicado: (2017)

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery
por: Wang, Xingxing, et al.
Publicado: (2021)

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma
por: Xu, Chen, et al.
Publicado: (2017)

Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification
por: Jiang, Dongxian, et al.
Publicado: (2020)

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2022)

SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2021)

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
por: Wang, Yanqiu, et al.
Publicado: (2019)

Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy
por: Jiang, Dongxian, et al.
Publicado: (2023)

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome
por: Huang, Jie, et al.
Publicado: (2021)

Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
por: Ming, Zizhen, et al.
Publicado: (2014)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
por: Song, Qi, et al.
Publicado: (2021)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

Identification of clinical prognostic features of esophageal cancer based on m6A regulators
por: Wang, Huimei, et al.
Publicado: (2022)

An alternative high output tissue microarray technique
por: Shi, Yuan, et al.
Publicado: (2013)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
por: Xu, Chen, et al.
Publicado: (2017)

Integrative proteogenomic characterization of early esophageal cancer
por: Li, Lingling, et al.
Publicado: (2023)

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
por: Li, Yan, et al.
Publicado: (2022)

Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
por: Li, Yan, et al.
Publicado: (2022)

Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2017)

Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients
por: Suo, Chen, et al.
Publicado: (2021)

Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck
por: Jones, T M
Publicado: (2014)

Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
por: Li, Qunxing, et al.
Publicado: (2020)

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
por: Noble, Fergus, et al.
Publicado: (2016)

The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China
por: Xue, Xuemin, et al.
Publicado: (2022)

Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
por: Tan, Qin, et al.
Publicado: (2019)

Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment
por: Chen, Weijie, et al.
Publicado: (2021)

Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis
por: Hao, Jiatao, et al.
Publicado: (2020)

A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma
por: Shaban, Muhammad, et al.
Publicado: (2019)

Identification of tumor-infiltrating lymphocyte subpopulations correlated with patient prognosis in esophageal squamous cell carcinoma
por: Peng, Lin, et al.
Publicado: (2021)

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
por: Wang, Yunzhi, et al.
Publicado: (2023)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes
por: Yamauchi, Takuro, et al.
Publicado: (2021)

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
por: Wu, Xianhua, et al.
Publicado: (2012)

Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma
por: Li, Zhuo, et al.
Publicado: (2023)

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
por: Naghavian, Reza, et al.
Publicado: (2023)

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma
por: Wang, Jianbo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_41sm7q179u7emdbeni2sathqq4